Capillus272™ Cleared by FDA for Treatment of Male and Female Pattern Hair Loss
Leonard Hair Transplant Associates Exclusively Offers Capillus272™ in New England
Boston, MA – (January 30, 2015)– Dr. Robert Leonard, Founder and Chief Surgeon of Leonard Hair Transplant Associates (LHTA), is pleased to announce that the Capillus272™low-level laser therapy device has been cleared by the Food and Drug Administration (FDA) for the treatment of androgenic alopecia (male and female pattern hair loss). LHTA is the only medical hair loss practice to offer the Capillus272™ to patients in New England.
The Capillus272™ is an innovative, mobile, battery-operated laser product that fits discreetly into a baseball cap. LHTA has been exclusively offering this device in its Massachusetts, Rhode Island and New Hampshire offices for the past three years. “I am extremely excited that the US Food and Drug Administration has provided clearance of the Capillus272 laser device for the treatment of male and female pattern hair loss,” said Dr. Robert Leonard. “I have been a strong advocate of low-level laser therapy for more than 15 years. At LHTA, we have treated more than 6,000 patients with this therapeutic method – more than any other hair restoration practice in the nation.”
With 272 lasers, the Capillus272™ emits more laser energy than any other low-level laser therapy product in the marketplace. Its FDA clearance is based on an independently reviewed clinical trial, and it’s indicated for the treatment in both men and women. It is lightweight and battery-powered and comfortably fits within a baseball cap for unnoticed, private use.
According to LHTA, the Capillus272™ provides superlative results while patients use it in the comfort of their homes or on the go. The device is worn for only one half hour, every other day. Patients can expect to notice results after approximately four months of use; however, a final medical evaluation takes place after one year of use.
About Leonard Hair Transplant Associates:
Leonard Hair Transplant Associates offers the latest technology in hair restoration surgery and medical treatments, including ARTAS® Robotic System, Hair Transplantation, NeoGraft™, Capillus Laser Cap, and PROPECIA®. With offices in Cranston, Rhode Island; Boston, Worcester, Hyannis, Braintree, and Newton Centre, Massachusetts; and Salem, New Hampshire; LHTA is dedicated to maintaining an honest, realistic medical evaluation of each individual’s hair loss problem.